|
|
Article: Research findings from University of California, Department of Neurological Surgery update understanding of brain cancer clinical trial.
- Article from:
- Cancer Weekly
- Article date:
- September 9, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Researchers detail in 'Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium,' new data in brain cancer. "The North American Brain Tumor Consortium (NABTC) is a multi-institutional consortium with the primary objective of evaluating novel therapeutic strategies through early phase clinical trials. The NABTC has made substantial changes to the design and methodology of its trials since its inception in 1994," scientists in the United States report (see also Brain Cancer Clinical Trial).
"These changes reflect developments in technology, new types of therapies, and advances in our understanding of ...